| Name | apolipoprotein E |
|---|---|
| Synonyms | AD2; APOE; Apo E; Apolipoprotein E; Apolipoprotein E precursor; apoprotein; Apo Es; Apolipoprotein Es… |
| Name | copper sulfate |
|---|---|
| CAS | sulfuric acid copper(2+) salt (1:1) |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 7055585 | Buhi WC, Gray WJ, Mansfield EA, Chun PW, Ducsay CA, Bazer FW, Roberts RM: content and molecular weight of uteroferrin and a comparison of its iron and forms. Biochim Biophys Acta. 1982 Feb 4;701(1):32-8. Reduction with dithionite leads to loss of iron, allowing the apoprotein to be prepared. |
3(0,0,0,3) | Details |
| 15896001 | Pham T, Kodvawala A, Hui DY: The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity. Biochemistry. 2005 May 24;44(20):7577-82. |
2(0,0,0,2) | Details |
| 12729008 | Arai H, Uchida K, Fukunaga K, Nagasaka Y, Mohri S, Furumoto H, Kuramitsu Y, Nakamura K: Effect of on the oxidative modification of apolipoprotein E in human very-low-density lipoprotein. Biosci Biotechnol Biochem. 2003 Feb;67(2):402-5. |
2(0,0,0,2) | Details |
| 10375392 | Arai H, Kashiwagi S, Nagasaka Y, Uchida K, Hoshii Y, Nakamura K: Oxidative modification of apolipoprotein E in human very-low-density lipoprotein and its inhibition by glycosaminoglycans. Arch Biochem Biophys. 1999 Jul 1;367(1):1-8. |
2(0,0,0,2) | Details |
| 2774578 | DiSilvestro RA: activation of superoxide dismutase in rat erythrocytes. . Arch Biochem Biophys. 1989 Oct;274(1):298-303. Several lines of evidence suggested that can activate a preexisting pool of superoxide dismutase (SOD) apoprotein in erythrocytes from -deficient rats. |
2(0,0,0,2) | Details |
| 12757429 | Goulter AB, Avella M, Botham KM, Elliott J: Chylomicron-remnant-like particles inhibit the basal nitric oxide pathway in porcine coronary artery and aortic endothelial cells. Clin Sci. 2003 Sep;105(3):363-71. The effects of chylomicron remnants on the activity of basally produced (NO) from porcine coronary artery rings and porcine aortic endothelial cells were studied by investigating the effects of chylomicron-remnant-like particles (CMR-LPs) containing porcine apolipoprotein E on the vessel tone of porcine coronary arteries and on release by aortic endothelial cells. |
1(0,0,0,1) | Details |
| 15999224 | Miyazaki K: A hyperthermophilic laccase from Thermus thermophilus HB27. Extremophiles. 2005 Dec;9(6):415-25. Epub 2005 Jul 6. The recombinant enzyme, expressed as an apoprotein, was dialyzed against -containing buffer to yield a holoprotein. |
1(0,0,0,1) | Details |
| 7545355 | Preobrazhensky S, Trakht I, Chestkov V, Wentz M: Monoclonal antibody-based immunoassay for evaluation of lipoprotein oxidation. Anal Biochem. 1995 May 1;227(1):225-34. In this paper we describe an immunochemical approach which can be used to measure the oxidation of isolated LDL and apoprotein B in unfractionated serum and to evaluate the effects of antioxidants on these processes. |
1(0,0,0,1) | Details |
| 15955453 | Rajasekaran NS, Sathyanarayanan S, Devaraj NS, Devaraj H: Chronic depletion of (GSH) and minimal modification of LDL in vivo: its prevention by mono ester (GME) therapy. Biochim Biophys Acta. 2005 Jun 30;1741(1-2):103-12. Epub 2004 Dec 15. Upon in vitro oxidation with CuSO (4), the electrophoretic behavior of purified LDL-apoprotein-B on agarose gel showed an increased mobility in BSO-treated rats, indicative of in vivo modification of LDL to become susceptible for in vitro oxidation. |
1(0,0,0,1) | Details |
| 12021277 | Hanasaki K, Yamada K, Yamamoto S, Ishimoto Y, Saiga A, Ono T, Ikeda M, Notoya M, Kamitani S, Arita H: Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation. J Biol Chem. 2002 Aug 9;277(32):29116-24. Epub 2002 May 20. Immunohistochemical analysis revealed marked expression of sPLA2-X in foam cell lesions in the arterial intima of high fat-fed apolipoprotein E-deficient mice. |
1(0,0,0,1) | Details |
| 9245700 | Keidar S, Attias J, Smith J, Breslow JL, Hayek T: The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun. 1997 Jul 30;236(3):622-5. |
4(0,0,0,4) | Details |
| 9554802 | Hayek T, Attias J, Smith J, Breslow JL, Keidar S: Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol. 1998 Apr;31(4):540-4. |
3(0,0,0,3) | Details |